来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

AED
现在位置首页>所有品牌>IRIS International
美国 . IRIS International
IRIS International

美国IRIS International www.proiris.com
Iris集团于1979年成立,总部位于洛杉矶北部,并在纳斯达克上市。Iris集团旗下包括:Iris诊断、Iris德国公司、Iris 分子诊断、Iris样品处理。其中Iris诊断一直致力于开发和研究体外诊断产品,为客户提供可靠的成本效益解决方案。经验丰富的研究人员不断地开发创新体外诊断技术以扩大最初的产品平台,因为不懈的努力,IRIS诊断的数字影像处理技术水平在业界领先,且是尿液分析系统的全球领导者。

2012年Danaher完成了对Iris公司的收购

美国IRIS International   美国丹纳赫集团Danaher Corporation 

Iris Sample   

美国Iris Diagnostics



Since 1979, IRIS International, Inc. (NASDAQ: IRIS), has been dedicated to the development and commercialization of innovative medical diagnostics and sample processing products that provide reliable and cost effective solutions for our customers and improved disease management for the patients we serve. IRIS invented and introduced the first automated urinalysis system and in the following years added numerous innovations and improvements, making us the world leader in this technology. Our automated urinalysis systems and sample processing products are today used in hospitals, clinical reference laboratories, veterinary laboratories and research facilities around the world.

Our management and scientists, engineers and senior technical staff with many years of healthcare experience have broadened our initial product platform and have successfully focused on the development and commercialization of innovative in-vitro diagnostics products and solutions, which expand our core imaging and morphology expertise into related markets of oncology, hematology, and microbiology.
Our manufacturing and research activities are conducted through three operating units: Iris Diagnostics Division, Iris Sample Processing Division (formerly StatSpin, Inc.) and Iris Molecular Diagnostics research and development subsidiary. The core competencies in these operating groups include flow imaging technology, morphological pattern recognition, chemistry, ultra-sensitive detection of proteins and rapid and reliable processing of blood and other body fluids. This broad expertise is now being utilized by Iris in the development of a series of "disruptive" technologies, which we believe will introduce a number of new products that will change and sharply advance the fields of urinalysis, hematology, cancer diagnostics and sample processing for human and veterinary applications.

Our 300+ employees take pride in our customers’ contributions to medical science and to improving the lives of patients and are especially aware of the role we play in providing our customers products and services which enable them to carry out their mission to provide better healthcare.